YB1 modulates the DNA damage response in medulloblastoma

Area of Science:

• Oncology
• Molecular Biology
• Radiation Oncology

Background:

• Y-box binding protein 1 (YB1) is an oncoprotein linked to cancer proliferation and therapy resistance.
• Medulloblastoma (MB), a common pediatric brain tumor, is treated with radiation and chemotherapy, but resistance remains a challenge.
• The role of YB1 in radiation resistance in MB, particularly its interaction with DNA repair pathways, is not well understood.

Purpose of the Study:

• To investigate the role of YB1 in mediating radiation resistance in medulloblastoma (MB).
• To explore the potential synergistic effects of YB1 inhibition with ionizing radiation (IR) in MB treatment.

Main Methods:

• YB1 depletion using shRNA in SHH and Group 3 MB cells.
• Exposure of YB1-depleted cells to ionizing radiation (IR).
• Analysis of DNA repair mechanisms (NHEJ), cell cycle progression, proliferation, and senescence.

Main Results:

• Depleting YB1 in MB cells reduced proliferation and synergized with IR.
• YB1 silencing followed by IR promoted a predominantly NHEJ-dependent DNA repair pathway.
• This resulted in faster DNA damage resolution (γH2AX), premature cell cycle re-entry, checkpoint bypass, reduced proliferation, and increased senescence.

Conclusions:

• YB1 depletion sensitizes SHH and Group 3 MB cells to radiation therapy.
• Targeting YB1 in combination with radiation may offer a novel therapeutic strategy for medulloblastoma.